ARCHIVES

Frank Torti Named FDA Deputy Commissioner, To Take Leave As Wake Forest Center Director.

This article is from The Cancer Letter archive.

Vol. 34 No. 14 | April 11, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Roper To Resign From CDC; Clinton Nominates Phillip Lee For Asst. Secretary For Health

March 19, 1993

NCCS Networker Volume 8 Issue 3, Fall 1994

September 12, 1994

“I’m Not Bummed Out By This” – Broder

December 22, 1994

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

New Center Plan Discussed By NAB, Directors Committees

May 4, 1990

Centers Program Needs ‘Innovative Additions’ Such as SPORE Grants

September 20, 1991